Artificial Intelligence and its developments have had a revolutionary impact on society, and healthcare is not an exception. China has made massive strides in AI integrated healthcare, and continues to do so as AI tools are deployed in hospitals across the country.
China’s ambitions for artificial intelligence are staggering. The country is projected to invest more than US$1.4 trillion into AI development by 2030, a figure that eclipses the GDP of many nations. But what’s perhaps more astonishing is where some of that investment is already landing: hospitals powered not by humans, but by AI doctors.
In 2024, Tsinghua University made headlines with the launch of the world’s first AI hospital, Agent Hospital—a concept that blends virtual AI agents, clinical care, and real-world pilot deployment into one tightly integrated system. Now that vision is being refined, tested, and expanded across China in what might be one of the most ambitious attempts to reimagine modern healthcare.
What is Agent Hospital, and why does it matter?
Tsinghua’s Agent Hospital was made up of 14 AI doctors upon launch. At its core, is MedAgent-Zero, the self-evolving AI framework developed by the University’s AIR (Institute for AI Industry Research). Moreover, in November of 2024, the “Zijing AI Doctor” was launched. Developed by a Tsinghua University spin-out start-up, Zijing Zhikang, to serve as the core component in AI Agent’s ecosystem.1 The system features 42 AI doctors across 21 clinical specialties, covering over 300 diseases. Furthermore, each specialty has trained its virtual agents on over ten common conditions. And finally, by creating a pool of half a million synthetic patient cases to test and evolve diagnostic accuracy. These AI doctors can treat 10,000 patients with 93% accuracy in a matter of days, a feat that would take real doctors years to complete.
Furthermore, these doctors aren’t chatbots; they’re AI systems capable of autonomously working with AI generated patients in a fully-fledged closed-loop ecosystem.
The system underwent internal testing in November of 2024, in which the closed-loop environment was used to rapidly and extensively evolve the AI doctor agents. Moreover, internal testing enabled vast simulation, and refinement using virtual patient data and clinical workflows. Consequently, the system was made ready to undergo public pilot testing, which has since greatly superseded internal testing.
Transition from Internal Simulation to Public Deployment
The inauguration ceremony for Tsinghua Agent Hospital held last April marked this transition into public deployment.2 During the event, the system’s integration with Chang Gung Hospital was announced, emphasizing the institute’s commitment and ambition to revolutionize healthcare.
From ophthalmology and respiratory medicine to radiological diagnostics, AI doctors take on tasks traditionally handled by their human counterparts—streamlining workflows, offering real-time recommendations, and lowering the barrier to care.
Garnering international attention, the event highlighted China’s AI Hospital model to address physician shortages, and improve healthcare access, especially in underserved regions.
Beyond clinical deployment and streamlining medical services, the system will serve as educational groundwork at Tsinghua. As a result, educational integration will catalyze the rise of a new generation of “AI-collaborative physicians.”
Beijing Tsinghua Chang Gung Hospital – Physical hospital, digital core
May 2025 marked a symbolic and strategic milestone: the Phase II expansion of Beijing Tsinghua Chang Gung Hospital, adding 500 new beds, raising its capacity to 1,500 inpatients and up to 10,000 outpatients daily.3 However, while the physical infrastructure grew, the real story was in the digital layer being embedded alongside it.
AI now supports nearly every step of the patient journey—from digital admissions and predictive alerts to infusion management, diagnostics, and mobile nursing stations. The hospital even partnered with the Tsinghua Academy of Arts and Design to incorporate “healing architecture,” merging technology with cultural aesthetics for a more human-centered experience.
This is not a case of slapping AI on top of a legacy system. This is a full rethinking of what a hospital can be when clinical need, AI capability, and design philosophy converge.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
